Simvastatin — brands & medicines in Pakistan
Pakistan mein Simvastatin ke 1 brands available hain. Drug class: Statin (HMG-CoA Reductase Inhibitor). Neeche se koi bhi brand select karein aur uses, dosage, side effects aur price dekhein.
Quick Answer
Simvastatin is a statin (hmg-coa reductase inhibitor) used in Pakistan for Hypercholesterolemia, Cardiovascular risk reduction (post-MI, atherosclerosis prevention), Familial hypercholesterolemia. Available as 1 brand. Prescription required. Always confirm dose with a doctor or pharmacist.
What is Simvastatin?
Simvastatin is a statin (hmg-coa reductase inhibitor) used in Pakistan for a range of medical conditions. Doctors and pharmacists in Pakistan recognize Simvastatin under multiple brand names — currently 1 listed on PakVita (1 tablet). The information below is a synthesis from DRAP-registered medicine entries, BNF, and WHO Essential Medicines references.
Common indications
- Hypercholesterolemia
- Cardiovascular risk reduction (post-MI, atherosclerosis prevention)
- Familial hypercholesterolemia
Indication and dose vary by medical condition, age, weight, and other factors. Always confirm with a qualified doctor or pharmacist before starting.
Typical dosage
As prescribed — take in the evening; cholesterol synthesis peaks at night
This is a general adult guidance pattern based on the manufacturer's label for one of the Simvastatin brands listed below. Children, elderly patients, pregnant women, and people with kidney or liver impairment usually need different dosing — confirm with your doctor.
Side effects
Common (usually mild)
- Myalgia
- Headache
- GI disturbances (nausea, diarrhea, constipation)
Serious — stop and see a doctor
- Myopathy / rhabdomyolysis (severe muscle breakdown — dark urine = kidney emergency)
- Hepatotoxicity (liver damage — jaundice sign)
- New-onset diabetes (class effect — statins)
Important warnings
- Simvastatin 80mg is RESTRICTED — high myopathy / rhabdomyolysis risk; do NOT use 80mg
- Report unexplained muscle pain or weakness immediately — sign of rhabdomyolysis
- Liver function monitoring is necessary
- Avoid grapefruit juice — CYP3A4 inhibition raises statin levels
- Strong CYP3A4 inhibitors (itraconazole, clarithromycin, HIV protease inhibitors) CONTRAINDICATED — rhabdomyolysis risk
- Max Simvastatin dose with Amiodarone is 20mg
Drug class
Statins (Cholesterol Medicines)Simvastatin brands in Pakistan (1)
Click any brand to see full uses, dosage, side effects, prices, and warnings.
Frequently asked questions
What is Simvastatin used for in Pakistan?
Simvastatin is commonly used for Hypercholesterolemia, Cardiovascular risk reduction (post-MI, atherosclerosis prevention), Familial hypercholesterolemia. It belongs to the statin (hmg-coa reductase inhibitor) drug class.
What is the typical dosage of Simvastatin?
Typical adult dosing is described by manufacturers as: "As prescribed — take in the evening; cholesterol synthesis peaks at night". Always confirm dose, duration, and timing with a qualified doctor or pharmacist — dose depends on indication, weight, age, kidney/liver function, and other medications.
What are the common side effects of Simvastatin?
Common side effects include Myalgia, Headache, GI disturbances (nausea, diarrhea, constipation). Most are mild and resolve as the body adjusts. Stop the medicine and contact a doctor if side effects are severe, persistent, or include allergic symptoms (rash, swelling, breathing difficulty).
When should I stop Simvastatin and see a doctor?
Stop Simvastatin and seek urgent medical care if you experience: Myopathy / rhabdomyolysis (severe muscle breakdown — dark urine = kidney emergency); Hepatotoxicity (liver damage — jaundice sign); New-onset diabetes (class effect — statins). These are serious signs that need immediate attention.
Is Simvastatin available without a prescription in Pakistan?
Prescription required.
What brands of Simvastatin are available in Pakistan?
1 brand of Simvastatin is listed on PakVita: 1 tablet. Browse the brand list below and click any name for prices, dosage, and full information.
Sources
- DRAP Registered Drug Products Database — Drug Regulatory Authority of Pakistan
- British National Formulary (BNF) — BMJ Group & Pharmaceutical Press
- WHO Model List of Essential Medicines, 23rd ed. — World Health Organization